Cancer risk with JAK inhibitors versus TNF inhibitors

被引：0
|
作者：
Thorley, Jennifer
机构：
来源：
LANCET RHEUMATOLOGY | 2023年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e252 / e252
页数：1
相关论文
共 50 条
  • [21] In RA, new use of JAK inhibitors was associated with nonmelanoma skin cancer vs. TNF inhibitors at 2 y
    Schattner, Ami
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (07) : JC83 - JC83
  • [22] Safety of tofacitinib versus TNF inhibitors
    Brooks, Helen
    Clark, Anna
    Van Epps, Heather
    LANCET RHEUMATOLOGY, 2022, 4 (01): : E18 - E18
  • [23] Malignancy with tofacitinib versus TNF inhibitors
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2023, 5 (02): : E66 - E66
  • [24] RISK OF CARDIOVASCULAR EVENTS, CANCER, AND ALL- CAUSE MORTALITY IN JAK INHIBITORS COMPARED TO TNF INHIBITORS: ANALYSIS OF A LARGE REAL-WORLD CLAIMS DATABASE
    Argoubi, R.
    Nowacki, G.
    Furegato, M.
    Purinton, S.
    Medina, P.
    VALUE IN HEALTH, 2024, 27 (12)
  • [25] TNF-α inhibitors don't increase risk of cancer
    Reactions Weekly, 2014, 1509 (1) : 5 - 5
  • [26] JAK inhibitors increase risk of thrombosis, MI, stroke, cancer and death
    Reactions Weekly, 2022, 1925 (1) : 1 - 1
  • [27] JAK inhibitors increase risk of MI, thrombosis, cancer and serious infections
    Reactions Weekly, 2023, 1951 (1) : 3 - 3
  • [28] Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy
    Amstad, Andrea
    Papagiannoulis, Eleftherios
    Scherer, Almut
    Rubbert-Roth, Andrea
    Finckh, Axel
    Mueller, Ruediger
    Dudler, Jean
    Moeller, Burkhard
    Villiger, Peter M.
    Schulz, Martin M. P.
    Kyburz, Diego
    RHEUMATOLOGY, 2022, 62 (01) : 89 - 97
  • [29] TNF-α inhibitors: risk of hypoglycaemia
    Reactions Weekly, 2022, 1917 (1) : 12 - 12
  • [30] SAFETY PROFILE OF JAK-INHIBITORS VERSUS TNF-INHIBITORS IN REAL-WORLD CLINICAL PRACTICE: DATA FROM A MULTICENTER REGISTER
    Hernandez-Cruz, B.
    Sanchez-Piedra, C.
    Freire Gonzalez, M.
    Busquets, N.
    Garcia-Gonzalez, J.
    Moreno, M.
    Blanco, J. M.
    Manrique Arija, S.
    Perez-Pampin, E.
    Sanchez-Alonso, F.
    Castrejon, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 68 - 69
12345